[Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine]

Lakartidningen. 2010 Mar;107(10):672-5.
[Article in Swedish]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / metabolism*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology*
  • Cell Proliferation
  • Chemotherapy, Adjuvant
  • Cyclin A / metabolism*
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Ki-67 Antigen / metabolism*
  • Mitotic Index
  • Prognosis
  • Reproducibility of Results

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Cyclin A
  • Ki-67 Antigen